
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $20.5M | -- | -- | -- | -- |
08/14/2025 | Q2 | $10.2M | -- | -- | -- | -- |
06/27/2025 | Q1 | $14.3M | $15.6M | $0.04 | -- | -- |
02/13/2025 | Q4 | $36.4M | $40.7M | $0.34 | -- | -- |
11/14/2024 | Q3 | $10.7M | $12.7M | -$0.09 | -- | -- |
08/14/2024 | Q2 | $10.3M | $9.1M | -$0.20 | -- | -- |
03/31/2024 | Q1 | $10.6M | $9.9M | -$1.19 | -- | -- |
02/14/2024 | Q4 | $13.8M | $13.3M | -$0.22 | -- | -- |
09/30/2023 | Q3 | $13.5M | $13M | -$0.04 | -- | -- |
06/30/2023 | Q2 | $12.7M | $13M | -$0.37 | -- | -- |
03/31/2023 | Q1 | $13.2M | $12.5M | -$0.35 | -- | -- |
02/14/2023 | Q4 | -- | $27.9M | $0.55 | -- | -- |
09/30/2022 | Q3 | -- | $14M | -$0.65 | -- | -- |
06/30/2022 | Q2 | -- | $13.6M | -$0.69 | -- | -- |
03/31/2022 | Q1 | -- | $16.9M | -$0.40 | -- | -- |
12/31/2021 | Q4 | -- | $14.1M | -$0.05 | -- | -- |
09/30/2021 | Q3 | -- | $10.1M | -$0.03 | -- | -- |
06/30/2021 | Q2 | -- | $15M | $0.60 | -- | -- |
03/31/2021 | Q1 | -- | $8.3M | -- | -- | -- |
12/31/2020 | Q4 | -- | $10M | -$1.40 | -- | -- |
09/30/2020 | Q3 | -- | $7.2M | -$4.60 | -- | -- |
06/30/2020 | Q2 | -- | $6M | -$4.20 | -- | -- |
03/31/2020 | Q1 | -- | $7.7M | -$1.60 | -- | -- |
12/31/2019 | Q4 | -- | $11.5M | -$1.00 | -- | -- |
09/30/2019 | Q3 | -- | $10.2M | -$1.60 | -- | -- |
06/30/2019 | Q2 | -- | $9.8M | -$2.60 | -- | -- |
03/31/2019 | Q1 | -- | $12.1M | -$3.40 | -- | -- |
12/31/2018 | Q4 | -- | $14.6M | -$1.80 | -- | -- |
09/30/2018 | Q3 | -- | $13.7M | -$1.80 | -- | -- |
06/30/2018 | Q2 | -- | $13.1M | -$1.80 | -- | -- |
03/31/2018 | Q1 | -- | $17.7M | -$0.02 | -- | -- |
12/31/2017 | Q4 | -- | $18.5M | -$4.00 | -- | -- |
09/30/2017 | Q3 | -- | $16.3M | -$12.00 | -- | -- |
06/30/2017 | Q2 | -- | $15.2M | -$9.60 | -- | -- |
03/31/2017 | Q1 | -- | $19.6M | -$22.80 | -- | -- |
12/31/2016 | Q4 | -- | $24.4M | -$1.40 | -- | -- |
09/30/2016 | Q3 | -- | $23.9M | -$1.60 | -- | -- |
06/30/2016 | Q2 | -- | $22.5M | -$14.00 | -- | -- |
03/31/2016 | Q1 | -- | $23.2M | -$19.00 | -- | -- |
12/31/2015 | Q4 | -- | $30.7M | -$8.00 | -- | -- |
09/30/2015 | Q3 | -- | $27.7M | -$71.00 | -- | -- |
Cineverse reported $15.6M worth of top line sales in its most recent quarter.
Cineverse announced earnings per share of $0.04 which represents a beat of analyst forecast a -- per share.
Cineverse reported $19.7M that represents $1.11 per share over the last quarter.
Cineverse's earnings are forecast to grow from $0.16 per share to -- per share next year representing an increase of --.
Cineverse's next earnings date is August 14, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.